Clinical Trials
3 trialsNCT00474760 2013-12-17
Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors
Pfizer
Phase 1 Completed
NCT00976508 2013-12-13
Figitumumab Combined With Pegvisomant For Advanced Solid Tumors
Pfizer
Phase 1 Terminated
NCT00927966 2013-11-14
RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms
Dana-Farber Cancer Institute
Phase 1 Completed